Brief: Stayble Therapeutics Gets Approved Patent In South Africa For Treatment Of Disc Herniation
Sept 5 (Reuters) - Stayble Therapeutics AB STABL.ST :
* RECEIVES ITS FIRST APPROVED PATENT FOR THE TREATMENT OF
DISC
HERNIATION
* SOUTH AFRICAN PATENT OFFICE AS FIRST COUNTRY TO HAVE
APPROVED
CO'S PATENT TREATMENT OF HERNIATED DISC WITH STA363
* PATENT PROVIDES PROTECTION UNTIL 2040
Source text for Eikon: ID:nWkr48CtDd
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln